Advisors Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$52.7K Sell
933
-476
-34% -$27.8K ﹤0.01% 1294
2025
Q4
$83.7K Sell
1,409
-1,387
-50% -$75.5K ﹤0.01% 1252
2025
Q3
$151K Sell
2,796
-289
-9% -$16.5K ﹤0.01% 1166
2025
Q2
$170K Sell
3,085
-751
-20% -$44.2K ﹤0.01% 1135
2025
Q1
$271K Sell
3,836
-388
-9% -$26.1K 0.01% 1061
2024
Q4
$278K Sell
4,224
-7,227
-63% -$484K 0.01% 1060
2024
Q3
$805K Buy
11,451
+180
+2% +$15K 0.01% 789
2024
Q2
$928K Buy
11,271
+889
+9% +$74K 0.02% 751
2024
Q1
$907K Buy
10,382
+1,240
+14% +$111K 0.02% 760
2023
Q4
$881K Sell
9,142
-991
-10% -$87.7K 0.02% 750
2023
Q3
$897K Buy
10,133
+612
+6% +$54.5K 0.02% 745
2023
Q2
$825K Buy
9,521
+1,083
+13% +$102K 0.02% 804
2023
Q1
$821K Buy
8,438
+1,159
+16% +$120K 0.02% 819
2022
Q4
$753K Buy
7,279
+6,887
+1,757% +$647K 0.02% 839
2022
Q3
$33K Sell
392
-575
-59% -$51.2K ﹤0.01% 1397
2022
Q2
$80K Sell
967
-11,675
-92% -$930K ﹤0.01% 1316
2022
Q1
$975K Sell
12,642
-743
-6% -$62.2K 0.02% 812
2021
Q4
$1.18M Sell
13,385
-262
-2% -$21.6K 0.02% 786
2021
Q3
$1.05M Sell
13,647
-5,942
-30% -$469K 0.02% 796
2021
Q2
$1.64M Sell
19,589
-126
-0.6% -$9.99K 0.02% 662
2021
Q1
$1.49M Sell
19,715
-1,658
-8% -$135K 0.02% 691
2020
Q4
$1.87M Buy
21,373
+3,873
+22% +$307K 0.03% 580
2020
Q3
$1.33M Buy
17,500
+8,010
+84% +$810K 0.02% 622
2020
Q2
$1.17M Buy
9,490
+6,329
+200% +$629K 0.02% 648
2020
Q1
$267K Buy
3,161
+57
+2% +$4.91K 0.01% 1039
2019
Q4
$262K Sell
3,104
-103
-3% -$7.78K ﹤0.01% 1140
2019
Q3
$216K Sell
3,207
-215
-6% -$16.6K ﹤0.01% 1171
2019
Q2
$293K Sell
3,422
-134
-4% -$11.5K 0.01% 1110
2019
Q1
$316K Sell
3,556
-3,758
-51% -$348K 0.01% 1221
2018
Q4
$623K Sell
7,314
-2,621
-26% -$249K 0.01% 920
2018
Q3
$963K Sell
9,935
-842
-8% -$84K 0.02% 848
2018
Q2
$1.01M Sell
10,777
-4,452
-29% -$390K 0.02% 835
2018
Q1
$1.24M Sell
15,229
-508
-3% -$43.6K 0.02% 759
2017
Q4
$1.4M Sell
15,737
-468
-3% -$40.7K 0.02% 708
2017
Q3
$1.51M Sell
16,205
-5,814
-26% -$514K 0.03% 707
2017
Q2
$2M Sell
22,019
-410
-2% -$37.3K 0.03% 627
2017
Q1
$1.97M Sell
22,429
-6,651
-23% -$592K 0.03% 638
2016
Q4
$2.41M Sell
29,080
-218
-0.7% -$18.7K 0.04% 574
2016
Q3
$2.71M Sell
29,298
-9,929
-25% -$935K 0.04% 527
2016
Q2
$3.05M Sell
39,227
-3,507
-8% -$298K 0.05% 524
2016
Q1
$3.52M Sell
42,734
-10,667
-20% -$868K 0.06% 458
2015
Q4
$5.59M Sell
53,401
-4,506
-8% -$471K 0.09% 323
2015
Q3
$6.1M Sell
57,907
-11,449
-17% -$1.53M 0.1% 294
2015
Q2
$9.49M Buy
69,356
+7,617
+12% +$944K 0.13% 217
2015
Q1
$7.69M Buy
61,739
+5,632
+10% +$597K 0.1% 255
2014
Q4
$5.07M Sell
56,107
-3,021
-5% -$251K 0.07% 341
2014
Q3
$4.27M Buy
59,128
+899
+2% +$59.1K 0.06% 381
2014
Q2
$3.62M Buy
58,229
+6,955
+14% +$420K 0.05% 423
2014
Q1
$3.5M Buy
51,274
+6,761
+15% +$498K 0.05% 399
2013
Q4
$3.13M Buy
44,513
+9,067
+26% +$616K 0.05% 414
2013
Q3
$2.56M Buy
35,446
+9,773
+38% +$650K 0.05% 439
2013
Q2
$1.43M Buy
+25,673
New +$1.6M 0.03% 544

Other funds holding BMRN